NDC11 50242013601
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50242-0136-01 | 50242-0136 |
| 50242-0136-1 | 50242-0136 |
| 50242-136-01 | 50242-136 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACTEMRA | TOCILIZUMAB | Genentech, Inc. | 2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 50242-136-01 50242-136 50242013601 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.